Open Access

In vivo ossification of a scaffold combining β‑tricalcium phosphate and platelet‑rich plasma

  • Authors:
    • Da Zhong
    • Cheng‑Gong Wang
    • Ke Yin
    • Qiande Liao
    • Xing Zhou
    • An‑Song Liu
    • Ling‑Yu Kong
  • View Affiliations

  • Published online on: September 15, 2014     https://doi.org/10.3892/etm.2014.1969
  • Pages: 1381-1388
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tricalcium phosphate (TCP) and platelet‑rich plasma (PRP) are commonly used in bone tissue engineering. The aim of the present study was to investigate a composite that combined TCP with PRP and assess its effectiveness in the treatment of bone defects. Cavity‑shaped bone defects were established on the tibiae of 27 beagle dogs, and were repaired by pure β‑TCP with bone marrow stromal cells (BMSCs), β‑TCP/PRP with BMSCs and autogenic ilium. The samples were harvested at 4, 8 and 12 weeks, and bone regeneration was evaluated using X‑ray radiography, immunocytochemical staining of osteocalcin (OCN), hematoxylin and eosin staining and reverse transcription‑polymerase chain reaction analyses. Biomechanical tests of the scaffolds were performed at the 12th week after scaffold implantation. When using pure β‑TCP as a scaffold, the scaffold‑bone interface was clear and no material adsorption and bone healing was observed. Substantial bone regeneration was observed when the tibial defects were restored using β‑TCP/PRP and autogenic ilium. Furthermore, the mRNA expression levels of OCN, alkaline phosphatase and collagen type I α1 were significantly higher in the animals with β‑TCP/PRP scaffolds at 8 and 12 weeks following implantation compared with those in the animals with the pure β‑TCP scaffolds. The maximum load and compressive strength of the β‑TCP/PRP scaffolds were similar to those of the autogenic ilium; however, they were significantly higher than those of the pure β‑TCP scaffold. Thus, the β‑TCP/PRP composite may be used as a potential scaffold to carry in vitro cultured BMSCs to treat bone defects.
View Figures
View References

Related Articles

Journal Cover

November-2014
Volume 8 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhong D, Wang CG, Yin K, Liao Q, Zhou X, Liu AS and Kong LY: In vivo ossification of a scaffold combining β‑tricalcium phosphate and platelet‑rich plasma. Exp Ther Med 8: 1381-1388, 2014
APA
Zhong, D., Wang, C., Yin, K., Liao, Q., Zhou, X., Liu, A., & Kong, L. (2014). In vivo ossification of a scaffold combining β‑tricalcium phosphate and platelet‑rich plasma. Experimental and Therapeutic Medicine, 8, 1381-1388. https://doi.org/10.3892/etm.2014.1969
MLA
Zhong, D., Wang, C., Yin, K., Liao, Q., Zhou, X., Liu, A., Kong, L."In vivo ossification of a scaffold combining β‑tricalcium phosphate and platelet‑rich plasma". Experimental and Therapeutic Medicine 8.5 (2014): 1381-1388.
Chicago
Zhong, D., Wang, C., Yin, K., Liao, Q., Zhou, X., Liu, A., Kong, L."In vivo ossification of a scaffold combining β‑tricalcium phosphate and platelet‑rich plasma". Experimental and Therapeutic Medicine 8, no. 5 (2014): 1381-1388. https://doi.org/10.3892/etm.2014.1969